In factor Xa inhibitor-related acute ICH, andexanet vs. usual care improved hemostatic efficacy but increased thrombotic events.

Authors :: Hunter BR
Kirschner JM
Source :: Annals of internal medicine [Ann Intern Med] 2024 Sep; Vol. 177 (9), pp. JC101. Date of Electronic Publication: 2024 Sep 03.
Publication Year :: 2024
Abstract: Source Citation: Connolly SJ, Sharma M, Cohen AT, et al; ANNEXA-I Investigators. Andexanet for factor Xa inhibitor-associated acute intracerebral hemorrhage. N Engl J Med. 2024;390:1745-1755. 38749032.<br />Competing Interests: Disclosures: Disclosure forms are available with the article online.

Subjects :: Humans
Cerebral Hemorrhage chemically induced
Male
Recombinant Proteins
Factor Xa
Factor Xa Inhibitors adverse effects
Factor Xa Inhibitors therapeutic use
Thrombosis chemically induced

Full Text Access

Tools